Skip to content

Changed body fat distribution and its correlation with glucose and lipid metabolism in obese patients: an observational study

Changed body fat distribution and its correlation with glucose and lipid metabolism in obese patients: an observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066123
Enrollment
Unknown
Registered
2022-11-24
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity, diabetes

Interventions

NA:NA

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients were eligible if they: 1. Fulfilled the criterion for overweight or obesity (BMI >= 24kg/m^2); waist circumference >= 90cm for adult males, waist circumference >= 90cm for adult females, or waist-hip ratio > 1.0. 2. Aged over 18 years old ; 3. Without receiving any medications that influenced glucose and lipid metabolism or weight loss surgery; 4. Finished venous blood collection and MRI examination.

Exclusion criteria

Exclusion criteria: Patients were deemed not eligible for the study if they: 1. Diagnosed as secondary obesity, such as hypothyroidism, Cushing syndrome, polycystic ovary syndrome (PCOS); 2. Severe cardiovascular and cerebrovascular diseases and rheumatic immune disease; 3. Severe metabolism diseases, such as diabetic ketoacidosis and hyperosmolar hyperglycemic state; 4. Advanced malignant neoplasm; 5. Previous use of glucocorticoids, antibiotics, antidiabetic agents, antidepressant or antianxiety medications that influenced glucose and lipid metabolism; 6. Did not finish venous blood collection; 7. Did not finish MRI examination; 8. Had other conditions that the researchers deemed inappropriate for the study.

Design outcomes

Primary

MeasureTime frame
visceral adipose tissue;blood glucose;insulin;C-Peptide;glycated hemoglobin;fat content in skeletal muscle;

Secondary

MeasureTime frame
blood lipid;inflammatory factor(IL-2, IL-6, IL- 8, IL-10, TNF-a);

Countries

China

Contacts

Public ContactJing Ma
majing@renji.com+86 158 0098 3436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026